SXTP
60 Degrees Pharmaceuticals, Inc. Common Stock
NASDAQ: SXTP · HEALTHCARE · BIOTECHNOLOGY
$1.57
-1.88% today
Updated 2026-04-29
Market cap
$4.22M
P/E ratio
—
P/S ratio
2.99x
EPS (TTM)
$-11.73
Dividend yield
—
52W range
$1 – $15
Volume
1.4M
60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-200.0%
Last 4 quarters
Revenue YoY growth
+16.0%
Most recent quarter
EPS YoY growth
-278.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.1%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+2.0%
2025-12-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $-8.17 | -308.6% | $0.51 | $0.52 | +2.0% |
| 2025-11-28 | $-0.67 | -737.5% | $1.05 | $1.03 | -1.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-2.00 | $-8.17 | -308.6% | $303385.00 | +16.0% |
| 2025-09-30 | $-0.08 | $-0.67 | -737.5% | $437602.00 | +223.4% |
| 2025-06-30 | $-0.10 | $-1.26 | -1160.0% | $100932.00 | -19.2% |
| 2025-03-31 | $-0.11 | $-1.55 | -1309.1% | $163552.00 | +54.8% |
| 2024-12-31 | $-0.18 | $-2.16 | -1100.0% | $261440.00 | +512.2% |
| 2024-09-30 | $-0.22 | $-0.93 | -322.7% | $135293.00 | +164.3% |
| 2024-06-30 | $-0.21 | $-4.24 | -1919.0% | $124972.00 | +109.9% |
| 2024-03-31 | $-0.15 | $0.03 | +120.0% | $105674.00 | — |
| 2023-12-31 | $-0.14 | $-0.35 | -146.4% | $42707.00 | — |
| 2023-09-30 | $0.95 | $0.77 | -18.9% | $51188.00 | — |
| 2023-06-30 | $0.00 | $-1.10 | — | $59532.00 | — |
Frequently asked questions
Has 60 Degrees Pharmaceuticals, Inc. Common Stock beaten earnings estimates?
60 Degrees Pharmaceuticals, Inc. Common Stock has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -200.0% over the last 4 quarters.
How does SXTP stock react to earnings?
SXTP stock has moved an average of +0.1% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is 60 Degrees Pharmaceuticals, Inc. Common Stock's revenue growth rate?
60 Degrees Pharmaceuticals, Inc. Common Stock reported year-over-year revenue growth of +16.0% in its most recent quarter, with EPS growing -278.3% year-over-year.